Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 System
NCT01148862 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2017-03-30
Summary
The purpose of this study is to assess the efficacy of the Low Glucose Suspend (LGS) feature in reducing hypoglycemia with the MiniMed Paradigm® X54 System with hypoglycemic induction from exercise.
The study will consist of a total of 50 subjects, age 16 through 60 years with Type 1 Diabetes Mellitus.
Conditions
- Type 1 Diabetes Mellitus
Interventions
- DEVICE
-
The MiniMed Paradigm® X54 System
The MiniMed Paradigm® X54 System: A insulin pump equipped with a number of features to actively manage the user's glucose levels. One example is the "Low Glucose Suspend (LGS)" feature. The LGS feature is only available when the pump is used with the subcutaneous glucose sensor for continuous glucose monitoring. To use this feature, the user will be required to select a sensor low suspend limit, or threshold, at which the LGS feature will be triggered. When this feature is selected, if the sensor glucose reading reaches the level that is equal to or less than the programmed threshold, the user receives an alert and the pump suspends.
Sponsors & Collaborators
-
Medtronic Diabetes
lead INDUSTRY
Principal Investigators
-
Bruce Buckingham, MD · Stanford University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 16 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2011-11-30
- Completion
- 2011-11-30
Countries
- United States
Study Locations
More Related Trials
-
The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
NCT02660242 ·Status: COMPLETED ·Phase: PHASE2
-
Closed-Loop Glucagon Administration For Hypoglycemia Treatment
NCT02181127 ·Status: COMPLETED ·Phase: NA
-
Hybrid Closed Loop Insulin Delivery System in Hypoglycemia
NCT03215914 ·Status: COMPLETED ·Phase: NA
-
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
NCT00441129 ·Status: COMPLETED ·Phase: NA
-
A Study of LY900014 in a Medtronic Pump
NCT03760640 ·Status: COMPLETED ·Phase: PHASE2
-
Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
NCT02135068 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study Comparing User Experience of Different Delivery Devices for Glucagon
NCT03765502 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Insulin Pump in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe Hypoglycemia
NCT02657213 ·Status: COMPLETED ·Phase: NA
-
United Kingdom User Evaluation, MiniMed Paradigm® X54 System
NCT01267175 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
NCT04585776 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
NCT02081014 ·Status: COMPLETED ·Phase: PHASE2
-
Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
NCT02411578 ·Status: COMPLETED ·Phase: PHASE2
-
Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software
NCT00552734 ·Status: COMPLETED
-
Insulin Degludec Titration Using Mobile Insulin Dosing System
NCT03091712 ·Status: COMPLETED ·Phase: NA
-
Glucose Counterregulation in Long Standing Type 1 Diabetes
NCT01474889 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia
NCT01919385 ·Status: COMPLETED ·Phase: PHASE1
-
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
NCT01755416 ·Status: COMPLETED ·Phase: PHASE2
-
"MiniMed 640G System" User Evaluation With the Question of Reducing the Rate of Hypoglycemia
NCT02325193 ·Status: COMPLETED
-
Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
NCT02402933 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®
NCT05325294 ·Status: COMPLETED ·Phase: NA
-
Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics
NCT00499954 ·Status: COMPLETED
-
A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes
NCT04667182 ·Status: WITHDRAWN
-
Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes
NCT02855307 ·Status: COMPLETED ·Phase: PHASE2
-
Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas
NCT03859401 ·Status: COMPLETED ·Phase: NA
-
Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump in Children
NCT02179281 ·Status: COMPLETED ·Phase: NA